Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
Holmberg
C
C
Division of Pediatric Nephrology and Transplantation, Children's Hospital, University of Helsinki, Finland.
Laine
J
J
Jalanko
H
H
Leijala
M
M
Hoppu
K
K
D000284:Administration, Oral; D000704:Analysis of Variance; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D004655:Emulsions; D005919:Glomerular Filtration Rate; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007408:Intestinal Absorption; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology
D004304:Dosage Forms; D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine